Ruta Snieckute

Ms. Ruta Snieckute

Life Sciences Center, Amyloid Research Sector, Vilnius University, Vilnius, Vilniaus Miestas, Lithuania
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MZMantas Ziaunys
Mantas Ziaunys
ASAndrius Sakalauskas
Andrius Sakalauskas
KMKamile Mikalauskaite
Kamile Mikalauskaite
RSRuta Snieckute
Ruta Snieckute
Vytautas SmirnovasVytautas Smirnovas
Vytautas Smirnovas
Prion protein aggregation into amyloid fibrils is associated with the onset and progression of prion diseases—a group of neurodegenerative amyloidoses. The process of such aggregate formation is still not fully understood, especially regarding their polymorphism, an event where the same type of protein forms multiple, conformationally and morphologically distinct structures. Considering that such structural variations can greatly complicate the search for potential antiamyloid compounds, either by having specific propagation properties or stability, it is important to better understand this aggregation event. We have recently reported the ability of prion protein fibrils to obtain at least two distinct conformations under identical conditions, which raised the question if this occurrence is tied to only certain environmental conditions. In this work, we examined a large sample size of prion protein aggregation reactions under a range of temperatures and analyzed the resulting fibril dye-binding, secondary structure and morphological properties. We show that all temperature conditions lead to the formation of more than one fibril type and that this variability may depend on the state of the initial prion protein molecules.

7 September 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
ASAndrius Sakalauskas
Andrius Sakalauskas
MZMantas Ziaunys
Mantas Ziaunys
RSRuta Snieckute
Ruta Snieckute
Vytautas SmirnovasVytautas Smirnovas
Vytautas Smirnovas
The increasing prevalence of amyloid-related disorders, such as Alzheimer’s or Parkinson’s disease, raises the need for effective anti-amyloid drugs. It has been shown on numerous occasions that flavones, a group of naturally occurring anti-oxidants, can impact the aggregation process of several amyloidogenic proteins and peptides, including amyloid-beta. Due to flavone autoxidation at neutral pH, it is uncertain if the effective inhibitor is the initial molecule or a product of this reaction, as many anti-amyloid assays attempt to mimic physiological conditions. In this work, we examine the aggregation-inhibiting properties of flavones before and after they are oxidized. The oxidation of flavones was monitored by measuring the UV-vis absorbance spectrum change over time. The protein aggregation kinetics were followed by measuring the amyloidophilic dye thioflavin-T (ThT) fluorescence intensity change. Atomic force microscopy was employed to image the aggregates formed with the most prominent inhibitors. We demonstrate that flavones, which undergo autoxidation, have a far greater potency at inhibiting the aggregation of both the disease-related amyloid-beta, as well as a model amyloidogenic protein—insulin. Oxidized 6,2′,3′-trihydroxyflavone was the most potent inhibitor affecting both insulin (7-fold inhibition) and amyloid-beta (2-fold inhibition). We also show that this tendency to autoxidize is related to the positions of the flavone hydroxyl groups.

Verified
Journal Article
Open access
PDF file
ASAndrius Sakalauskas
Andrius Sakalauskas
MZMantas Ziaunys
Mantas Ziaunys
RSRuta Snieckute
Ruta Snieckute
AJAgne Janoniene
Agne Janoniene
DVDominykas Veiveris
Dominykas Veiveris
Vytautas SmirnovasVytautas Smirnovas
Vytautas Smirnovas
The main pathological hallmark of Alzheimer’s disease (AD) is the aggregation of amyloid-β into amyloid fibrils, leading to a neurodegeneration cascade. The current medications are far from sufficient to prevent the onset of the disease, hence requiring more research to find new alternative drugs for curing AD. In vitro inhibition experiments are one of the primary tools in testing whether a molecule may be potent to impede the aggregation of amyloid-beta peptide (Aβ42). However, kinetic experiments in vitro do not match the mechanism found when aggregating Aβ42 in cerebrospinal fluid. The different aggregation mechanisms and the composition of the reaction mixtures may also impact the characteristics of the inhibitor molecules. For this reason, altering the reaction mixture to resemble components found in cerebrospinal fluid (CSF) is critical to partially compensate for the mismatch between the inhibition experiments in vivo and in vitro. In this study, we used an artificial cerebrospinal fluid that contained the major components found in CSF and performed Aβ42 aggregation inhibition studies using oxidized epigallocatechin-3-gallate (EGCG) and fluorinated benzenesulfonamide VR16-09. This led to a discovery of a complete turnaround of their inhibitory characteristics, rendering EGCG ineffective while significantly improving the efficacy of VR16-09. HSA was the main contributor in the mixture that significantly increased the anti-amyloid characteristics of VR16-09.

20 November 2025 in Advanced Science
Verified
Journal Article
Open access
RSRuta Snieckute
Ruta Snieckute
DSDarius Sulskis
Darius Sulskis
AJArūnė Jocytė
Arūnė Jocytė
UVUrtė Venclovaitė
Urtė Venclovaitė
RTRimgailė Tamulytė
Rimgailė Tamulytė
ASAndrius Sakalauskas
Andrius Sakalauskas
α‐Synuclein (aSyn) is an intrinsically disordered protein involved in neurotransmission and synaptic plasticity. The pathological aggregation of this protein is a hallmark of synucleinopathies such as Parkinson's disease (PD) or Multiple System Atrophy (MSA). Misfolded aSyn, which primarily originates in the cell cytosol, transmits between neurons, promoting a prion‐like propagation. However, extracellular environments such as interstitial and cerebrospinal fluids (ISF & CSF) play a major role in its clearance and pathological transformation. The molecular components of CSF, including proteins, glycosaminoglycans, and metal ions, may influence the aggregate morphology, structure, and cytotoxicity to cells. To better understand how extracellular composition affects aggregates and their formation, artificial cerebrospinal fluid (aCSF) is employed to mimic potential aggregation processes occurring in CSF. Distinct aSyn fibrils are observed that exhibited low stability outside aCSF, and the removal of key CSF components led to its structural alterations. Cryo‐electron microscopy revealed that these fibrils possess an electron density pocket coordinated with polar basic AAs (K43, K45, H50) that is also observed in aggregates obtained from PD and MSA patients. The findings illustrate the importance of physiologically relevant conditions in studying aSyn aggregation and may explain why disease‐related fibril structure replication in vitro has not yet been successful.

24 September 2024 in Chemistry – A European Journal
Verified
Journal Article
Closed access
MŽMantas Žvirblis
Mantas Žvirblis
ASAndrius Sakalauskas
Andrius Sakalauskas
SJSaeid Hadi Ali Janvand
Saeid Hadi Ali Janvand
VDVirginija Dudutienė
Virginija Dudutienė
MZMantas Ziaunys
Mantas Ziaunys
DMDaumantas Matulis
Daumantas Matulis

28 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MZMantas Ziaunys
Mantas Ziaunys
DSDarius Sulskis
Darius Sulskis
DVDominykas Veiveris
Dominykas Veiveris
AKAurimas Kopustas
Aurimas Kopustas
RSRuta Snieckute
Ruta Snieckute
Vytautas SmirnovasVytautas Smirnovas
Vytautas Smirnovas
Protein liquid-liquid phase separation (LLPS) is a rapidly emerging field of study on biomolecular condensate formation. In recent years, this phenomenon has been implicated in the process of amyloid fibril formation, serving as an intermediate step between the native protein transition into their aggregated state. The formation of fibrils via LLPS has been demonstrated for a number of proteins related to neurodegenerative disorders, as well as other amyloidoses. Despite the surge in amyloid-related LLPS studies, the influence of protein condensate formation on the end-point fibril characteristics is still far from fully understood. In this work, we compare alpha-synuclein aggregation under conditions, which promote or negate its LLPS and examine the differences between the formed aggregates. We show that alpha-synuclein phase separation generates a wide variety of assemblies with distinct secondary structures and morphologies. The LLPS-induced structures also possess higher levels of toxicity to cells, indicating that biomolecular condensate formation may be a critical step in the appearance of disease-related fibril variants.